Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Zhu, Ying  [Clear All Filters]
Journal Article
Onorati M, Li Z, Liu F, Sousa AMM, Nakagawa N, Li M, Dell'Anno MTeresa, Gulden FO, Pochareddy S, Tebbenkamp ATN, et al. Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human Neuroepithelial Stem Cells and Radial Glia. Cell Rep. 2016.
Xu J, Gui GSang Wang, Yang C, Zhu S, Chen Z, Ma SLang Bai, Yang C, Bu CRen Luo, Zhu Y, Xu W. USP3 inhibition is Active Against Chemo-resistant Hepatocellular Carcinoma Anchorage-independent Growth via Suppressing Wnt/β-catenin. Curr Mol Med. 2023.
Li G, Zhou L, Zhu Y, Wang C, Sha S, Xian X, Ji Y, Liu G, Chen L. Seipin knockout impairs proliferation and differentiation of adult stem/progenitor cells in hippocampal dentate gyrus via reduction of PPARγ. Dis Model Mech. 2015.
Zinzani PLuigi, Ramchandren R, Santoro A, Paszkiewicz-Kozik E, Gasiorowski R, Johnson NA, Oliveira JSR, Buccheri V, Perini GFleury, Dickinson M, et al. Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma. Blood Adv. 2021.
Kuruvilla J, Ramchandren R, Santoro A, Paszkiewicz-Kozik E, Gasiorowski R, Johnson NA, Fogliatto LMaria, Goncalves I, de Oliveira JSR, Buccheri V, et al. Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study. Lancet Oncol. 2021.
Cong M, Ai S, Kang L, Jin M, Zhu Y, Li C, Jin Z, Yu L, Wu D, Huang H. Outcomes of allogeneic hematopoietic stem cell transplantation in R/R DLBCL patients with failure of CAR-T therapy. Exp Hematol Oncol. 2024;13(1):4.
Vavassori S, Chou J, Faletti LEva, Haunerdinger V, Opitz L, Joset P, Fraser CJ, Prader S, Gao X, Schuch LA, et al. Multisystem Inflammation and Susceptibility to Viral infections in Human ZNFX1 Deficiency. J Allergy Clin Immunol. 2021.
Alt C, Yuan S, Wu F, Stankovich B, Calaoagan J, Schopies S, Wu JY, Shen J, Schneider D, Zhu Y, et al. Long-acting IL-33 mobilizes High-Quality Hematopoietic Stem and Progenitor Cells more efficiently than G-CSF or AMD3100. Biol Blood Marrow Transplant. 2019.
Hou Y, Wang Q, Su L, Zhu Y, Xiao Y, Feng F. Increased tumor-associated mast cells facilitate thyroid cancer progression by inhibiting CD8+ T cell function through galectin-9. Braz J Med Biol Res. 2023;56:e12370.
Yang J, Su J, Xi S-S, Ke X-F, Zhu Y, Lin H-P, Zeng X-K, Liu B-W, Zhu M-L, Dai W-Y, et al. Human umbilical cord mesenchymal stem cells pretreated with Angiotensin-II attenuate pancreas injury of rats with severe acute pancreatitis. Biomed Pharmacother. 2019;117:109052.
Zhu Y, Li C, Shuai R, Huang Z, Chen F, Wang Y, Zhou Q, Chen J. Experimental study of the mechanism of induction of conjunctival goblet cell hyperexpression using CHIR-99021 in vitro. Biochem Biophys Res Commun. 2023;668:104-110.
Fu L, Pang B, Zhu Y, Wang L, Leng A, Chen H. Ex Vivo Stromal Cell-Derived Factor 1-Mediated Differentiation of Mouse Bone Marrow Mesenchymal Stem Cells into Hepatocytes Is Enhanced by Chinese Medicine Yiguanjian Drug-Containing Serum. Evid Based Complement Alternat Med. 2016;2016:7380439.
Xiao M-H, Lin Y-F, Xie P-P, Chen H-X, Deng J-W, Zhang W, Zhao N, Xie C, Meng Y, Liu X, et al. Down-regulation of a Mitochondrial Micropeptide MPM Promotes Hepatoma Metastasis by Enhancing Mitochondrial Complex I Activity. Mol Ther. 2021.
Gao X, Sheng Y, Yang J, Wang C, Zhang R, Zhu Y, Zhang Z, Zhang K, Yan S, Sun H, et al. Correction: Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44 + cancer stem cells to 5 azacytidine in hepatocellular carcinoma. J Exp Clin Cancer Res. 2023;42(1):266.